.

Nektar Therapeutics reported $861.99M in Assets for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Assets Change
Agios Pharmaceuticals AGIO:US $ 1252.47M 83.39M
ALKERMES ALKS:US $ 1957.42M 20.43M
Amgen AMGN:US $ 59294M 98M
Astrazeneca AZN:US $ 96579M 3694M
Baxter International BAX:US $ 31831M 885M
Biocryst Pharmaceuticals BCRX:US $ 510.54M 17.18M
Biogen BIIB:US $ 25081.4M 1467M
Bluebird Bio BLUE:US $ 573.59M 82.52M
Bristol Myers Squibb BMY:US $ 100357M 2677M
Cara Therapeutics CARA:US $ 226.57M 2.71M
Eisai 4523:JP Y 1272871M 33556M
Eli Lilly And LLY:US $ 47063.6M 144.3M
Esperion Therapeutics ESPR:US $ 303.98M 38.87M
Exelixis EXEL:US $ 2881.4M 227.29M
Gilead Sciences GILD:US $ 62870M 210M
GlaxoSmithKline GSK:LN 8904500M 64400M
Halozyme Therapeutics HALO:US $ 1781.39M 619.14M
Immunogen IMGN:US $ 422.3M 59.41M
IONIS PHARMACEUT IONS:US $ 2456.13M 62.96M
Ironwood Pharmaceuticals IRWD:US $ 975.69M 107.69M
Karyopharm Therapeutics KPTI:US $ 256.48M 37.56M
Macrogenics MGNX:US $ 218.04M 53.4M
Mirati Therapeutics MRTX:US $ 1279.79M 141.51M
Nektar Therapeutics NKTR:US $ 861.99M 162.13M
Neurocrine Biosciences NBIX:US $ 2005.7M 138.8M
Novartis NOVN:VX SF 122910M 2308M
Sarepta Therapeutics SRPT:US $ 2996.85M 59.3M
Seattle Genetics SGEN:US $ 3630.34M 13.65M
Takeda 4502:JP Y 14065426M 887408M
Teva Pharmaceutical TEVA:IT 45.93B 1.13B
Xencor XNCR:US $ 851.32M 6.6M
YTE INCY:US $ 5319.04M 264.81M